paragraph_index int64 | sec string | p_has_citation int64 | cites string | citeids list | pmid int64 | cited_id string | sentences string | all_sent_cites list | sent_len int64 | sentence_batch_index int64 | sent_has_citation float64 | qc_fail bool | cited_sentence string | cites_in_sentence list | cln_sentence string | is_cap bool | is_alpha bool | ends_wp bool | cit_qc bool | lgtm bool | __index_level_0__ int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B6"
] | 18,162,708 | pmid-3056758|pmid-9279450|pmid-8971083|pmid-9686693|pmid-11368702|NA|pmid-9603539|pmid-3056758|pmid-9279450|NA | In this report, the components and criteria were set up more succinctly than those of the WHO. | [
"1",
"2",
"3",
"4",
"5",
"6"
] | 94 | 39,516 | 0 | false | In this report, the components and criteria were set up more succinctly than those of the WHO. | [] | In this report, the components and criteria were set up more succinctly than those of the WHO. | true | true | true | true | true | 6,818 |
0 | INTRODUCTION | 1 | 6 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B6"
] | 18,162,708 | pmid-3056758|pmid-9279450|pmid-8971083|pmid-9686693|pmid-11368702|NA|pmid-9603539|pmid-3056758|pmid-9279450|NA | In 2002, the American College of Endocrinology/American Association of Clinical Endocrinologists (ACE/AACE) suggested new diagnostic criteria for metabolic syndrome that highlighted the role of insulin resistance (6). | [
"1",
"2",
"3",
"4",
"5",
"6"
] | 217 | 39,517 | 1 | false | In 2002, the American College of Endocrinology/American Association of Clinical Endocrinologists (ACE/AACE) suggested new diagnostic criteria for metabolic syndrome that highlighted the role of insulin resistance. | [
"6"
] | In 2002, the American College of Endocrinology/American Association of Clinical Endocrinologists (ACE/AACE) suggested new diagnostic criteria for metabolic syndrome that highlighted the role of insulin resistance. | true | true | true | true | true | 6,818 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B6"
] | 18,162,708 | pmid-3056758|pmid-9279450|pmid-8971083|pmid-9686693|pmid-11368702|NA|pmid-9603539|pmid-3056758|pmid-9279450|NA | These clinical diagnostic criteria were simplified to be applied more easily. | [
"1",
"2",
"3",
"4",
"5",
"6"
] | 77 | 39,518 | 0 | false | These clinical diagnostic criteria were simplified to be applied more easily. | [] | These clinical diagnostic criteria were simplified to be applied more easily. | true | true | true | true | true | 6,818 |
1 | INTRODUCTION | 1 | 7 | [
"B7"
] | 18,162,708 | pmid-1884900 | In the San Antonio Study (7), which is the representative epidemiological study that supports the concept of IRS, the prevalence of obesity, type 2 diabetes, impaired glucose intolerance, hypertension, hypertriglyceridemia, and hypercholesterolemia among 2,930 people was investigated. | [
"7"
] | 285 | 39,519 | 1 | false | In the San Antonio Study, which is the representative epidemiological study that supports the concept of IRS, the prevalence of obesity, type 2 diabetes, impaired glucose intolerance, hypertension, hypertriglyceridemia, and hypercholesterolemia among 2,930 people was investigated. | [
"7"
] | In the San Antonio Study, which is the representative epidemiological study that supports the concept of IRS, the prevalence of obesity, type 2 diabetes, impaired glucose intolerance, hypertension, hypertriglyceridemia, and hypercholesterolemia among 2,930 people was investigated. | true | true | true | true | true | 6,819 |
1 | INTRODUCTION | 1 | 7 | [
"B7"
] | 18,162,708 | pmid-1884900 | Among the 2,930 participants, results obtained from 1,881 (64%) people who had at least one disease showed that the insulin concentration in serum, both fasting and after glucose tolerance, was positively associated with body mass index (BMI), systolic and diastolic pressure, and the concentration of both triglyceride ... | [
"7"
] | 351 | 39,520 | 0 | false | Among the 2,930 participants, results obtained from 1,881 (64%) people who had at least one disease showed that the insulin concentration in serum, both fasting and after glucose tolerance, was positively associated with body mass index (BMI), systolic and diastolic pressure, and the concentration of both triglyceride ... | [] | Among the 2,930 participants, results obtained from 1,881 (64%) people who had at least one disease showed that the insulin concentration in serum, both fasting and after glucose tolerance, was positively associated with body mass index (BMI), systolic and diastolic pressure, and the concentration of both triglyceride ... | true | true | true | true | true | 6,819 |
1 | INTRODUCTION | 1 | 7 | [
"B7"
] | 18,162,708 | pmid-1884900 | Furthermore, serum insulin was positively associated with the concentration of low high-density lipoprotein (HDL) cholesterol. | [
"7"
] | 126 | 39,521 | 0 | false | Furthermore, serum insulin was positively associated with the concentration of low high-density lipoprotein (HDL) cholesterol. | [] | Furthermore, serum insulin was positively associated with the concentration of low high-density lipoprotein (HDL) cholesterol. | true | true | true | true | true | 6,819 |
1 | INTRODUCTION | 1 | 7 | [
"B7"
] | 18,162,708 | pmid-1884900 | From these data, it was concluded that these diseases were significantly correlated with both fasting and post-prandial insulin concentration in serum, due to the strong association between hyperinsulinemia and insulin resistance. | [
"7"
] | 230 | 39,522 | 0 | false | From these data, it was concluded that these diseases were significantly correlated with both fasting and post-prandial insulin concentration in serum, due to the strong association between hyperinsulinemia and insulin resistance. | [] | From these data, it was concluded that these diseases were significantly correlated with both fasting and post-prandial insulin concentration in serum, due to the strong association between hyperinsulinemia and insulin resistance. | true | true | true | true | true | 6,819 |
2 | INTRODUCTION | 0 | null | null | 18,162,708 | pmid-3883799|pmid-11333990 | IRS, which causes serious clinical manifestations and is associated with cardiovascular disease and type 2 diabetes, is remarkable not only in the fields of endocrinology and cardiology, but also is becoming one of the most important problems in public health. | null | 260 | 39,523 | 0 | false | null | null | IRS, which causes serious clinical manifestations and is associated with cardiovascular disease and type 2 diabetes, is remarkable not only in the fields of endocrinology and cardiology, but also is becoming one of the most important problems in public health. | true | true | true | true | true | 6,820 |
2 | INTRODUCTION | 0 | null | null | 18,162,708 | pmid-3883799|pmid-11333990 | It was estimated that IRS in populations with risk factors of cardiovascular disease will increase gradually with expansion of the obese population in the future. | null | 162 | 39,524 | 0 | false | null | null | It was estimated that IRS in populations with risk factors of cardiovascular disease will increase gradually with expansion of the obese population in the future. | true | true | true | true | true | 6,820 |
2 | INTRODUCTION | 0 | null | null | 18,162,708 | pmid-3883799|pmid-11333990 | There were no researches that applied the renewed diagnostic criteria of the ACE/AACE, and it was difficult to find a study of the incidence of IRS in Korea. | null | 157 | 39,525 | 0 | false | null | null | There were no researches that applied the renewed diagnostic criteria of the ACE/AACE, and it was difficult to find a study of the incidence of IRS in Korea. | true | true | true | true | true | 6,820 |
3 | INTRODUCTION | 0 | null | null | 18,162,708 | NA|NA | Therefore, we determined the incidence of IRS based on the diagnostic criteria of the ACE/AACE and the risk factors that influence its development. | null | 147 | 39,526 | 0 | false | null | null | Therefore, we determined the incidence of IRS based on the diagnostic criteria of the ACE/AACE and the risk factors that influence its development. | true | true | true | true | true | 6,821 |
0 | DISCUSSION | 1 | 8 | [
"B8",
"B1",
"B2",
"B9"
] | 18,162,708 | pmid-3056758|pmid-9279450|pmid-8971083|pmid-9686693|pmid-11368702|NA|pmid-9603539|pmid-3056758|pmid-9279450|NA | Age, smoking, hypertension, high LDL cholesterol, low HDL cholesterol, high blood sugar, lack of physical activity, and blood coagulation times are known risk factors for cardiovascular disease (8). | [
"8",
"1",
"2",
"9"
] | 198 | 39,527 | 1 | false | Age, smoking, hypertension, high LDL cholesterol, low HDL cholesterol, high blood sugar, lack of physical activity, and blood coagulation times are known risk factors for cardiovascular disease. | [
"8"
] | Age, smoking, hypertension, high LDL cholesterol, low HDL cholesterol, high blood sugar, lack of physical activity, and blood coagulation times are known risk factors for cardiovascular disease. | true | true | true | true | true | 6,822 |
0 | DISCUSSION | 1 | 9 | [
"B8",
"B1",
"B2",
"B9"
] | 18,162,708 | pmid-3056758|pmid-9279450|pmid-8971083|pmid-9686693|pmid-11368702|NA|pmid-9603539|pmid-3056758|pmid-9279450|NA | The combination of these factors in an individual (1, 2) and the decline of glucose metabolism are recognized as the basis of IRS (9). | [
"8",
"1",
"2",
"9"
] | 134 | 39,528 | 1 | false | The combination of these factors in an individual and the decline of glucose metabolism are recognized as the basis of IRS. | [
"1, 2",
"9"
] | The combination of these factors in an individual and the decline of glucose metabolism are recognized as the basis of IRS. | true | true | true | true | true | 6,822 |
0 | DISCUSSION | 1 | 8 | [
"B8",
"B1",
"B2",
"B9"
] | 18,162,708 | pmid-3056758|pmid-9279450|pmid-8971083|pmid-9686693|pmid-11368702|NA|pmid-9603539|pmid-3056758|pmid-9279450|NA | Specifically, the ACE/AACE stated in 2003 that IRS was a clinical result of insulin resistance and its compensatory mechanism. | [
"8",
"1",
"2",
"9"
] | 126 | 39,529 | 0 | false | Specifically, the ACE/AACE stated in 2003 that IRS was a clinical result of insulin resistance and its compensatory mechanism. | [] | Specifically, the ACE/AACE stated in 2003 that IRS was a clinical result of insulin resistance and its compensatory mechanism. | true | true | true | true | true | 6,822 |
1 | DISCUSSION | 0 | null | null | 18,162,708 | pmid-1884900 | In this study, the age-adjusted annual incidence was 6.7 per 100 persons, which is considered to be relatively high. | null | 116 | 39,530 | 0 | false | null | null | In this study, the age-adjusted annual incidence was 6.7 per 100 persons, which is considered to be relatively high. | true | true | true | true | true | 6,823 |
1 | DISCUSSION | 0 | null | null | 18,162,708 | pmid-1884900 | The age group 20-29 showed the lowest incidence of 4.6 per 100 persons/year, while the age group 40-49 showed the highest incidence of 9.0 per 100 persons/year. | null | 160 | 39,531 | 0 | false | null | null | The age group 20-29 showed the lowest incidence of 4.6 per 100 persons/year, while the age group 40-49 showed the highest incidence of 9.0 per 100 persons/year. | true | true | true | true | true | 6,823 |
1 | DISCUSSION | 0 | null | null | 18,162,708 | pmid-1884900 | However, the incidence in the age group 50-59 had decreased to 6.6 per 100 persons/year. | null | 88 | 39,532 | 0 | false | null | null | However, the incidence in the age group 50-59 had decreased to 6.6 per 100 persons/year. | true | true | true | true | true | 6,823 |
1 | DISCUSSION | 0 | null | null | 18,162,708 | pmid-1884900 | The reasons for the decrease in incidence for this age group are thought to be as follows: 1) the number of subjects who were in their 50s was small, and 2) people in their 50s who were found to have IRS at the insulin resistance syndrome screening test had demonstrated evidence of IRS earlier in life. | null | 303 | 39,533 | 0 | false | null | null | The reasons for the decrease in incidence for this age group are thought to be as follows: 1) the number of subjects who were in their 50s was small, and 2) people in their 50s who were found to have IRS at the insulin resistance syndrome screening test had demonstrated evidence of IRS earlier in life. | true | true | true | true | true | 6,823 |
1 | DISCUSSION | 0 | null | null | 18,162,708 | pmid-1884900 | The RR for the 40-49 age group compared to the 20-29 age group was 1.95 (95% CI 1.10-3.46). | null | 91 | 39,534 | 0 | false | null | null | The RR for the 40-49 age group compared to the 20-29 age group was 1.95 (95% CI 1.10-3.46). | true | true | true | true | true | 6,823 |
1 | DISCUSSION | 0 | null | null | 18,162,708 | pmid-1884900 | Thus, the RR in the logistic regression analysis was increased 1.03 times (95% CI 1.00-1.05) with age, with every one-year increase. | null | 132 | 39,535 | 0 | false | null | null | Thus, the RR in the logistic regression analysis was increased 1.03 times (95% CI 1.00-1.05) with age, with every one-year increase. | true | true | true | true | true | 6,823 |
2 | DISCUSSION | 1 | 10 | [
"B10",
"B11"
] | 18,162,708 | pmid-3883799|pmid-11333990 | The environmental factors involved in the development of IRS include mental stress, lack of exercise, and visceral obesity in addition to age as mentioned above (10). | [
"10",
"11"
] | 166 | 39,536 | 1 | false | The environmental factors involved in the development of IRS include mental stress, lack of exercise, and visceral obesity in addition to age as mentioned above. | [
"10"
] | The environmental factors involved in the development of IRS include mental stress, lack of exercise, and visceral obesity in addition to age as mentioned above. | true | true | true | true | true | 6,824 |
2 | DISCUSSION | 1 | 11 | [
"B10",
"B11"
] | 18,162,708 | pmid-3883799|pmid-11333990 | WHR, smoking, LDL cholesterol and abnormal ALT showed significant association with IRS, after adjusting for several relevant factors in this study as well as in a previous study (11). | [
"10",
"11"
] | 183 | 39,537 | 1 | false | WHR, smoking, LDL cholesterol and abnormal ALT showed significant association with IRS, after adjusting for several relevant factors in this study as well as in a previous study. | [
"11"
] | WHR, smoking, LDL cholesterol and abnormal ALT showed significant association with IRS, after adjusting for several relevant factors in this study as well as in a previous study. | true | true | true | true | true | 6,824 |
3 | DISCUSSION | 1 | 12 | [
"B12",
"B13"
] | 18,162,708 | NA|NA | It is well known that obesity is closely associated with IRS, and that the accumulation of visceral fat correlates with the development of IRS. | [
"12",
"13"
] | 143 | 39,538 | 0 | false | It is well known that obesity is closely associated with IRS, and that the accumulation of visceral fat correlates with the development of IRS. | [] | It is well known that obesity is closely associated with IRS, and that the accumulation of visceral fat correlates with the development of IRS. | true | true | true | true | true | 6,825 |
3 | DISCUSSION | 1 | 12 | [
"B12",
"B13"
] | 18,162,708 | NA|NA | With regard to the correlation between IRS and WHR, which is the index of abdominal obesity, had a more significant correlation than BMI (12). | [
"12",
"13"
] | 142 | 39,539 | 1 | false | With regard to the correlation between IRS and WHR, which is the index of abdominal obesity, had a more significant correlation than BMI. | [
"12"
] | With regard to the correlation between IRS and WHR, which is the index of abdominal obesity, had a more significant correlation than BMI. | true | true | true | true | true | 6,825 |
3 | DISCUSSION | 1 | 13 | [
"B12",
"B13"
] | 18,162,708 | NA|NA | Heo and colleagues (13) reported that there was a significant correlation between visceral fat area measured by computerized axial tomography and insulin sensitivity. | [
"12",
"13"
] | 166 | 39,540 | 1 | false | Heo and colleagues reported that there was a significant correlation between visceral fat area measured by computerized axial tomography and insulin sensitivity. | [
"13"
] | Heo and colleagues reported that there was a significant correlation between visceral fat area measured by computerized axial tomography and insulin sensitivity. | true | true | true | true | true | 6,825 |
3 | DISCUSSION | 1 | 12 | [
"B12",
"B13"
] | 18,162,708 | NA|NA | In this study, the RR for the abdominal obesity group in which WHR was 0.9 or higher was 2.13 (95% CI, 1.64-2.77), showing a significant association with IRS development. | [
"12",
"13"
] | 170 | 39,541 | 0 | false | In this study, the RR for the abdominal obesity group in which WHR was 0.9 or higher was 2.13 (95% CI, 1.64-2.77), showing a significant association with IRS development. | [] | In this study, the RR for the abdominal obesity group in which WHR was 0.9 or higher was 2.13, showing a significant association with IRS development. | true | true | true | true | true | 6,825 |
4 | DISCUSSION | 1 | 10 | [
"B10",
"B14"
] | 18,162,708 | pmid-3883799|pmid-6341123 | It is known that both obesity and lack of physical activity account for about 25% of the cause of insulin resistance (10). | [
"10",
"14"
] | 122 | 39,542 | 1 | false | It is known that both obesity and lack of physical activity account for about 25% of the cause of insulin resistance. | [
"10"
] | It is known that both obesity and lack of physical activity account for about 25% of the cause of insulin resistance. | true | true | true | true | true | 6,826 |
4 | DISCUSSION | 1 | 14 | [
"B10",
"B14"
] | 18,162,708 | pmid-3883799|pmid-6341123 | The amount of physical activity is known to be closely related to insulin sensitivity, and maximum oxygen consumption is a factor that determines about 25% of insulin sensitivity in normal adults without type 2 diabetes (14). | [
"10",
"14"
] | 225 | 39,543 | 1 | false | The amount of physical activity is known to be closely related to insulin sensitivity, and maximum oxygen consumption is a factor that determines about 25% of insulin sensitivity in normal adults without type 2 diabetes. | [
"14"
] | The amount of physical activity is known to be closely related to insulin sensitivity, and maximum oxygen consumption is a factor that determines about 25% of insulin sensitivity in normal adults without type 2 diabetes. | true | true | true | true | true | 6,826 |
4 | DISCUSSION | 1 | 10 | [
"B10",
"B14"
] | 18,162,708 | pmid-3883799|pmid-6341123 | In this study, there was no significant difference in the incidence of IRS between the regular exercise group (exercised three or more times a week for 30 or more minutes at each time) and the non-regular exercise group, but the insulin concentration in blood after one year in the regular exercise was statistically sig... | [
"10",
"14"
] | 475 | 39,544 | 0 | false | In this study, there was no significant difference in the incidence of IRS between the regular exercise group (exercised three or more times a week for 30 or more minutes at each time) and the non-regular exercise group, but the insulin concentration in blood after one year in the regular exercise was statistically sig... | [] | In this study, there was no significant difference in the incidence of IRS between the regular exercise group and the non-regular exercise group, but the insulin concentration in blood after one year in the regular exercise was statistically significant lower than that of the non-regular exercise group. | true | true | true | true | true | 6,826 |
4 | DISCUSSION | 1 | 10 | [
"B10",
"B14"
] | 18,162,708 | pmid-3883799|pmid-6341123 | In this study, the RR of insulin resistance syndrome for the smoking group was 1.56 (95% CI, 1.11-2.19). | [
"10",
"14"
] | 104 | 39,545 | 0 | false | In this study, the RR of insulin resistance syndrome for the smoking group was 1.56 (95% CI, 1.11-2.19). | [] | In this study, the RR of insulin resistance syndrome for the smoking group was 1.56. | true | true | true | true | true | 6,826 |
4 | DISCUSSION | 1 | 10 | [
"B10",
"B14"
] | 18,162,708 | pmid-3883799|pmid-6341123 | After other risk factors were adjusted, the RR was 1.63 (95% CI, 1.09-2.42). | [
"10",
"14"
] | 76 | 39,546 | 0 | false | After other risk factors were adjusted, the RR was 1.63 (95% CI, 1.09-2.42). | [] | After other risk factors were adjusted, the RR was 1.63. | true | true | true | true | true | 6,826 |
4 | DISCUSSION | 1 | 10 | [
"B10",
"B14"
] | 18,162,708 | pmid-3883799|pmid-6341123 | Moreover, insulin concentrations in the plasma of the smoking group were statistically significantly higher than in the non-smoking group in this study (smoking group: 7.03±6.94 µIU/mL, non-smoking group: 6.38±6.04 µIU/mL, p<0.05). | [
"10",
"14"
] | 231 | 39,547 | 0 | false | Moreover, insulin concentrations in the plasma of the smoking group were statistically significantly higher than in the non-smoking group in this study (smoking group: 7.03±6.94 µIU/mL, non-smoking group: 6.38±6.04 µIU/mL, p<0.05). | [] | Moreover, insulin concentrations in the plasma of the smoking group were statistically significantly higher than in the non-smoking group in this study. | true | true | true | true | true | 6,826 |
5 | DISCUSSION | 1 | 15 | [
"B15",
"B16",
"B17"
] | 18,162,708 | pmid-9698022|pmid-2372896|pmid-8325978 | Godsland and colleagues (15) reported that insulin resistance is caused by the acute effect of smoking in the case of current smokers. | [
"15",
"16",
"17"
] | 134 | 39,548 | 1 | false | Godsland and colleagues reported that insulin resistance is caused by the acute effect of smoking in the case of current smokers. | [
"15"
] | Godsland and colleagues reported that insulin resistance is caused by the acute effect of smoking in the case of current smokers. | true | true | true | true | true | 6,827 |
5 | DISCUSSION | 1 | 15 | [
"B15",
"B16",
"B17"
] | 18,162,708 | pmid-9698022|pmid-2372896|pmid-8325978 | The RR for the group in which LDL cholesterol concentration was higher than 130 mg/dL but lower than 160 mg/dL and the group in which LDL cholesterol concentration was 160 mg/dL or higher were 1.44 (95% CI, 1.06-1.95) and | [
"15",
"16",
"17"
] | 221 | 39,549 | 0 | false | The RR for the group in which LDL cholesterol concentration was higher than 130 mg/dL but lower than 160 mg/dL and the group in which LDL cholesterol concentration was 160 mg/dL or higher were 1.44 (95% CI, 1.06-1.95) and | [] | The RR for the group in which LDL cholesterol concentration was higher than 130 mg/dL but lower than 160 mg/dL and the group in which LDL cholesterol concentration was 160 mg/dL or higher were 1.44 and | true | true | false | true | false | 6,827 |
5 | DISCUSSION | 1 | 15 | [
"B15",
"B16",
"B17"
] | 18,162,708 | pmid-9698022|pmid-2372896|pmid-8325978 | 4.77 (95% CI, 3.47-6.56), respectively, compared to the group in which LDL cholesterol concentration was 130 mg/dL or lower. | [
"15",
"16",
"17"
] | 124 | 39,550 | 0 | false | 4.77 (95% CI, 3.47-6.56), respectively, compared to the group in which LDL cholesterol concentration was 130 mg/dL or lower. | [] | 4.77, respectively, compared to the group in which LDL cholesterol concentration was 130 mg/dL or lower. | false | false | true | true | false | 6,827 |
5 | DISCUSSION | 1 | 15 | [
"B15",
"B16",
"B17"
] | 18,162,708 | pmid-9698022|pmid-2372896|pmid-8325978 | Furthermore, using logistic regression analysis in which other risk factors were adjusted, the RR for the group of which LDL cholesterol concentration was 160 mg/dL or higher was 1.70 (95% CI, 1.19-2.44). | [
"15",
"16",
"17"
] | 204 | 39,551 | 0 | false | Furthermore, using logistic regression analysis in which other risk factors were adjusted, the RR for the group of which LDL cholesterol concentration was 160 mg/dL or higher was 1.70 (95% CI, 1.19-2.44). | [] | Furthermore, using logistic regression analysis in which other risk factors were adjusted, the RR for the group of which LDL cholesterol concentration was 160 mg/dL or higher was 1.70. | true | true | true | true | true | 6,827 |
5 | DISCUSSION | 1 | 16 | [
"B15",
"B16",
"B17"
] | 18,162,708 | pmid-9698022|pmid-2372896|pmid-8325978 | It was recently found that small dense LDL cholesterol is a main factor of atherosclerosis (16) and is associated with insulin resistance (17); therefore, it is thought that disorder in lipid metabolism due to insulin resistance plays an important role in the development of atherosclerosis. | [
"15",
"16",
"17"
] | 291 | 39,552 | 1 | false | It was recently found that small dense LDL cholesterol is a main factor of atherosclerosis and is associated with insulin resistance ; therefore, it is thought that disorder in lipid metabolism due to insulin resistance plays an important role in the development of atherosclerosis. | [
"16",
"17"
] | It was recently found that small dense LDL cholesterol is a main factor of atherosclerosis and is associated with insulin resistance ; therefore, it is thought that disorder in lipid metabolism due to insulin resistance plays an important role in the development of atherosclerosis. | true | true | true | true | true | 6,827 |
6 | DISCUSSION | 1 | 18 | [
"B18",
"B18"
] | 18,162,708 | pmid-12031978|pmid-12031978 | Abnormal liver function was significantly associated with development of IRS, after viral hepatitis was excluded (18). | [
"18",
"18"
] | 118 | 39,553 | 1 | false | Abnormal liver function was significantly associated with development of IRS, after viral hepatitis was excluded. | [
"18"
] | Abnormal liver function was significantly associated with development of IRS, after viral hepatitis was excluded. | true | true | true | true | true | 6,828 |
6 | DISCUSSION | 1 | 18 | [
"B18",
"B18"
] | 18,162,708 | pmid-12031978|pmid-12031978 | In this study, the RR for the abnormal ALT group was 1.87 (95% CI, 1.45-2.41). | [
"18",
"18"
] | 78 | 39,554 | 0 | false | In this study, the RR for the abnormal ALT group was 1.87 (95% CI, 1.45-2.41). | [] | In this study, the RR for the abnormal ALT group was 1.87. | true | true | true | true | true | 6,828 |
6 | DISCUSSION | 1 | 18 | [
"B18",
"B18"
] | 18,162,708 | pmid-12031978|pmid-12031978 | Moreover, using logistic regression analysis after adjusting other risk factors, the RR for the abnormal ALT group was 1.70 (95% CI, 1.20-2.41). | [
"18",
"18"
] | 144 | 39,555 | 0 | false | Moreover, using logistic regression analysis after adjusting other risk factors, the RR for the abnormal ALT group was 1.70 (95% CI, 1.20-2.41). | [] | Moreover, using logistic regression analysis after adjusting other risk factors, the RR for the abnormal ALT group was 1.70. | true | true | true | true | true | 6,828 |
6 | DISCUSSION | 1 | 18 | [
"B18",
"B18"
] | 18,162,708 | pmid-12031978|pmid-12031978 | These results suggest an association between liver disease and IRS, agreeing with the results of a prerious study (18). | [
"18",
"18"
] | 119 | 39,556 | 1 | false | These results suggest an association between liver disease and IRS, agreeing with the results of a prerious study. | [
"18"
] | These results suggest an association between liver disease and IRS, agreeing with the results of a prerious study. | true | true | true | true | true | 6,828 |
6 | DISCUSSION | 1 | 18 | [
"B18",
"B18"
] | 18,162,708 | pmid-12031978|pmid-12031978 | Therefore, liver disease was correlated not only with problems of the liver itself but also with IRS, and this aspect points to the reason that nonalcoholic liver disease was selected as one of the components of IRS. | [
"18",
"18"
] | 216 | 39,557 | 0 | false | Therefore, liver disease was correlated not only with problems of the liver itself but also with IRS, and this aspect points to the reason that nonalcoholic liver disease was selected as one of the components of IRS. | [] | Therefore, liver disease was correlated not only with problems of the liver itself but also with IRS, and this aspect points to the reason that nonalcoholic liver disease was selected as one of the components of IRS. | true | true | true | true | true | 6,828 |
7 | DISCUSSION | 0 | null | null | 18,162,708 | null | This study had some limitations. | null | 32 | 39,558 | 0 | false | null | null | This study had some limitations. | true | true | true | true | true | 6,829 |
7 | DISCUSSION | 0 | null | null | 18,162,708 | null | First, the workplace-based participants do not represent the general Korean population. | null | 87 | 39,559 | 0 | false | null | null | First, the workplace-based participants do not represent the general Korean population. | true | true | true | true | true | 6,829 |
7 | DISCUSSION | 0 | null | null | 18,162,708 | null | Second, it involved a short-term follow-up period, and therefore, a causal relationship related to the development of IRS could not be defined. | null | 143 | 39,560 | 0 | false | null | null | Second, it involved a short-term follow-up period, and therefore, a causal relationship related to the development of IRS could not be defined. | true | true | true | true | true | 6,829 |
8 | DISCUSSION | 0 | null | null | 18,162,708 | null | The annual incidence of IRS in Korean workers is high; therefore, early diagnosis and early treatment are necessary. | null | 116 | 39,561 | 0 | false | null | null | The annual incidence of IRS in Korean workers is high; therefore, early diagnosis and early treatment are necessary. | true | true | true | true | true | 6,830 |
8 | DISCUSSION | 0 | null | null | 18,162,708 | null | It is necessary to develop methods of prevention and therapeutic approach to manage the integrated risk factors. | null | 112 | 39,562 | 0 | false | null | null | It is necessary to develop methods of prevention and therapeutic approach to manage the integrated risk factors. | true | true | true | true | true | 6,830 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2"
] | 18,063,570 | pmid-14681433|pmid-16219921 | PlantGDB serves the plant research community by providing access to plant sequence data as well as a variety of sequence and genome analysis tools in a single online resource [(1,2); Table 1]. | [
"1",
"2"
] | 192 | 39,563 | 0 | false | PlantGDB serves the plant research community by providing access to plant sequence data as well as a variety of sequence and genome analysis tools in a single online resource. | [
"(1,2); Table 1"
] | PlantGDB serves the plant research community by providing access to plant sequence data as well as a variety of sequence and genome analysis tools in a single online resource. | true | true | true | true | true | 6,831 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2"
] | 18,063,570 | pmid-14681433|pmid-16219921 | This update outlines recent developments at PlantGDB that have expanded its usefulness as a tool for comparative genomics. | [
"1",
"2"
] | 122 | 39,564 | 0 | false | This update outlines recent developments at PlantGDB that have expanded its usefulness as a tool for comparative genomics. | [] | This update outlines recent developments at PlantGDB that have expanded its usefulness as a tool for comparative genomics. | true | true | true | true | true | 6,831 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2"
] | 18,063,570 | pmid-14681433|pmid-16219921 | Key features include: expanded EST assemblies; new genome browsers for a larger number of species; overnight annotation of emerging genome sequences; and novel tools for sequence retrieval and analysis, including an innovative system for the creation and management of workflows that integrates database queries, linked ... | [
"1",
"2"
] | 350 | 39,565 | 0 | false | Key features include: expanded EST assemblies; new genome browsers for a larger number of species; overnight annotation of emerging genome sequences; and novel tools for sequence retrieval and analysis, including an innovative system for the creation and management of workflows that integrates database queries, linked ... | [] | Key features include: expanded EST assemblies; new genome browsers for a larger number of species; overnight annotation of emerging genome sequences; and novel tools for sequence retrieval and analysis, including an innovative system for the creation and management of workflows that integrates database queries, linked ... | true | true | true | true | true | 6,831 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2"
] | 18,063,570 | pmid-14681433|pmid-16219921 | Table 1.Sequence resources and analytical tools available at PlantGDBIn this table, sequence resources are divided into four categories: Uploaded Sequence, Assembled Sequence, Genome Browsers, and Other Tools. | [
"1",
"2"
] | 209 | 39,566 | 0 | false | Table 1.Sequence resources and analytical tools available at PlantGDBIn this table, sequence resources are divided into four categories: Uploaded Sequence, Assembled Sequence, Genome Browsers, and Other Tools. | [] | Table 1.Sequence resources and analytical tools available at PlantGDBIn this table, sequence resources are divided into four categories: Uploaded Sequence, Assembled Sequence, Genome Browsers, and Other Tools. | true | true | true | true | true | 6,831 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2"
] | 18,063,570 | pmid-14681433|pmid-16219921 | For each resource in column 1, the species available, source/version, current sequence count, update frequency, tool/services, download options, and alignment to genome are shown in adjacent cells. | [
"1",
"2"
] | 197 | 39,567 | 0 | false | For each resource in column 1, the species available, source/version, current sequence count, update frequency, tool/services, download options, and alignment to genome are shown in adjacent cells. | [] | For each resource in column 1, the species available, source/version, current sequence count, update frequency, tool/services, download options, and alignment to genome are shown in adjacent cells. | true | true | true | true | true | 6,831 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2"
] | 18,063,570 | pmid-14681433|pmid-16219921 | Web links for both external and internal data/tool sources are indicated with superscript numbers and are listed at the end of the table under Web Resources. | [
"1",
"2"
] | 157 | 39,568 | 0 | false | Web links for both external and internal data/tool sources are indicated with superscript numbers and are listed at the end of the table under Web Resources. | [] | Web links for both external and internal data/tool sources are indicated with superscript numbers and are listed at the end of the table under Web Resources. | true | true | true | true | true | 6,831 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2"
] | 18,063,570 | pmid-14681433|pmid-16219921 | Sequence counts displayed here are as of 30 October 2007. | [
"1",
"2"
] | 57 | 39,569 | 0 | false | Sequence counts displayed here are as of 30 October 2007. | [] | Sequence counts displayed here are as of 30 October 2007. | true | true | true | true | true | 6,831 |
1 | INTRODUCTION | 0 | null | null | 18,063,570 | null | Sequence resources and analytical tools available at PlantGDB | null | 61 | 39,570 | 0 | false | null | null | Sequence resources and analytical tools available at PlantGDB | true | true | false | true | false | 6,832 |
2 | INTRODUCTION | 0 | null | null | 18,063,570 | null | In this table, sequence resources are divided into four categories: Uploaded Sequence, Assembled Sequence, Genome Browsers, and Other Tools. | null | 140 | 39,571 | 0 | false | null | null | In this table, sequence resources are divided into four categories: Uploaded Sequence, Assembled Sequence, Genome Browsers, and Other Tools. | true | true | true | true | true | 6,833 |
2 | INTRODUCTION | 0 | null | null | 18,063,570 | null | For each resource in column 1, the species available, source/version, current sequence count, update frequency, tool/services, download options, and alignment to genome are shown in adjacent cells. | null | 197 | 39,572 | 0 | false | null | null | For each resource in column 1, the species available, source/version, current sequence count, update frequency, tool/services, download options, and alignment to genome are shown in adjacent cells. | true | true | true | true | true | 6,833 |
2 | INTRODUCTION | 0 | null | null | 18,063,570 | null | Web links for both external and internal data/tool sources are indicated with superscript numbers and are listed at the end of the table under Web Resources. | null | 157 | 39,573 | 0 | false | null | null | Web links for both external and internal data/tool sources are indicated with superscript numbers and are listed at the end of the table under Web Resources. | true | true | true | true | true | 6,833 |
2 | INTRODUCTION | 0 | null | null | 18,063,570 | null | Sequence counts displayed here are as of 30 October 2007. | null | 57 | 39,574 | 0 | false | null | null | Sequence counts displayed here are as of 30 October 2007. | true | true | true | true | true | 6,833 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B3",
"B4",
"B5",
"B6",
"B7"
] | 17,427,647 | NA|NA|pmid-10356155|pmid-10356155|pmid-9226216|pmid-1944469|pmid-1594625|pmid-10714367|pmid-3773215|pmid-10646121 | McCune-Albright syndrome (MAS) is a rare disease that was originally defined by the triad of polyostotic fibrous dysplasia of the bone (FD), caf-au-lait skin pigmentation and precocious puberty1, 2). | [
"1",
"2)",
"3)",
"3",
"4)",
"5",
"6)",
"7)"
] | 199 | 39,575 | 0 | false | McCune-Albright syndrome (MAS) is a rare disease that was originally defined by the triad of polyostotic fibrous dysplasia of the bone (FD), caf-au-lait skin pigmentation and precocious puberty1, 2). | [] | McCune-Albright syndrome (MAS) is a rare disease that was originally defined by the triad of polyostotic fibrous dysplasia of the bone (FD), caf-au-lait skin pigmentation and precocious puberty1, 2). | true | true | true | true | true | 6,834 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B3",
"B4",
"B5",
"B6",
"B7"
] | 17,427,647 | NA|NA|pmid-10356155|pmid-10356155|pmid-9226216|pmid-1944469|pmid-1594625|pmid-10714367|pmid-3773215|pmid-10646121 | A number of endocrine disorders such as hyperthyroidism, excess growth hormone (GH), Cushing syndrome3) and rickets/osteomalacia might be associated with MAS3, 4). | [
"1",
"2)",
"3)",
"3",
"4)",
"5",
"6)",
"7)"
] | 163 | 39,576 | 0 | false | A number of endocrine disorders such as hyperthyroidism, excess growth hormone (GH), Cushing syndrome3) and rickets/osteomalacia might be associated with MAS3, 4). | [] | A number of endocrine disorders such as hyperthyroidism, excess growth hormone (GH), Cushing syndrome3) and rickets/osteomalacia might be associated with MAS3, 4). | true | true | true | true | true | 6,834 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B3",
"B4",
"B5",
"B6",
"B7"
] | 17,427,647 | NA|NA|pmid-10356155|pmid-10356155|pmid-9226216|pmid-1944469|pmid-1594625|pmid-10714367|pmid-3773215|pmid-10646121 | The disease results from post zygotic activating mutations of the cAMP regulating protein, GNAS1 gene product, and Gs5, 6). | [
"1",
"2)",
"3)",
"3",
"4)",
"5",
"6)",
"7)"
] | 123 | 39,577 | 0 | false | The disease results from post zygotic activating mutations of the cAMP regulating protein, GNAS1 gene product, and Gs5, 6). | [] | The disease results from post zygotic activating mutations of the cAMP regulating protein, GNAS1 gene product, and Gs5, 6). | true | true | true | true | true | 6,834 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B3",
"B4",
"B5",
"B6",
"B7"
] | 17,427,647 | NA|NA|pmid-10356155|pmid-10356155|pmid-9226216|pmid-1944469|pmid-1594625|pmid-10714367|pmid-3773215|pmid-10646121 | Most Gs mutations are point mutations at the Arg201 position, with the majority being Arg201 | [
"1",
"2)",
"3)",
"3",
"4)",
"5",
"6)",
"7)"
] | 92 | 39,578 | 0 | false | Most Gs mutations are point mutations at the Arg201 position, with the majority being Arg201 | [] | Most Gs mutations are point mutations at the Arg201 position, with the majority being Arg201 | true | true | false | true | false | 6,834 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B3",
"B4",
"B5",
"B6",
"B7"
] | 17,427,647 | NA|NA|pmid-10356155|pmid-10356155|pmid-9226216|pmid-1944469|pmid-1594625|pmid-10714367|pmid-3773215|pmid-10646121 | His or Cys7). | [
"1",
"2)",
"3)",
"3",
"4)",
"5",
"6)",
"7)"
] | 13 | 39,579 | 0 | false | His or Cys7). | [] | His or Cys7). | true | true | true | true | true | 6,834 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B3",
"B4",
"B5",
"B6",
"B7"
] | 17,427,647 | NA|NA|pmid-10356155|pmid-10356155|pmid-9226216|pmid-1944469|pmid-1594625|pmid-10714367|pmid-3773215|pmid-10646121 | Recently, weevaluated a 23-year-old man with typical MAS who had FD, skin pigmentation and multiple endocrinopathies including acromegaly, hyperprolactinemia and a thyroid nodule. | [
"1",
"2)",
"3)",
"3",
"4)",
"5",
"6)",
"7)"
] | 179 | 39,580 | 0 | false | Recently, weevaluated a 23-year-old man with typical MAS who had FD, skin pigmentation and multiple endocrinopathies including acromegaly, hyperprolactinemia and a thyroid nodule. | [] | Recently, weevaluated a 23-year-old man with typical MAS who had FD, skin pigmentation and multiple endocrinopathies including acromegaly, hyperprolactinemia and a thyroid nodule. | true | true | true | true | true | 6,834 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B3",
"B4",
"B5",
"B6",
"B7"
] | 17,427,647 | NA|NA|pmid-10356155|pmid-10356155|pmid-9226216|pmid-1944469|pmid-1594625|pmid-10714367|pmid-3773215|pmid-10646121 | Genetic analysis confirmed a point mutation of the GNAS1 gene. | [
"1",
"2)",
"3)",
"3",
"4)",
"5",
"6)",
"7)"
] | 62 | 39,581 | 0 | false | Genetic analysis confirmed a point mutation of the GNAS1 gene. | [] | Genetic analysis confirmed a point mutation of the GNAS1 gene. | true | true | true | true | true | 6,834 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B3",
"B4",
"B5",
"B6",
"B7"
] | 17,427,647 | NA|NA|pmid-10356155|pmid-10356155|pmid-9226216|pmid-1944469|pmid-1594625|pmid-10714367|pmid-3773215|pmid-10646121 | We report this case with a review of the relevant literature. | [
"1",
"2)",
"3)",
"3",
"4)",
"5",
"6)",
"7)"
] | 61 | 39,582 | 0 | false | We report this case with a review of the relevant literature. | [] | We report this case with a review of the relevant literature. | true | true | true | true | true | 6,834 |
0 | DISCUSSION | 1 | 8) | [
"B8",
"B9"
] | 17,427,647 | NA|NA|pmid-10356155|pmid-10356155|pmid-9226216|pmid-1944469|pmid-1594625|pmid-10714367|pmid-3773215|pmid-10646121 | Typical MAS is characterized by FD with at least one of the typical hyperfunctioning endocrinopathies along with caf-au-lait spots. | [
"8)",
"9)"
] | 131 | 39,583 | 0 | false | Typical MAS is characterized by FD with at least one of the typical hyperfunctioning endocrinopathies along with caf-au-lait spots. | [] | Typical MAS is characterized by FD with at least one of the typical hyperfunctioning endocrinopathies along with caf-au-lait spots. | true | true | true | true | true | 6,835 |
0 | DISCUSSION | 1 | 8) | [
"B8",
"B9"
] | 17,427,647 | NA|NA|pmid-10356155|pmid-10356155|pmid-9226216|pmid-1944469|pmid-1594625|pmid-10714367|pmid-3773215|pmid-10646121 | Unlike a typical case of MAS, patients with FD and more than two endocrine disorders without skin pigmentation or precocious puberty are defined as having atypical MAS8). | [
"8)",
"9)"
] | 170 | 39,584 | 0 | false | Unlike a typical case of MAS, patients with FD and more than two endocrine disorders without skin pigmentation or precocious puberty are defined as having atypical MAS8). | [] | Unlike a typical case of MAS, patients with FD and more than two endocrine disorders without skin pigmentation or precocious puberty are defined as having atypical MAS8). | true | true | true | true | true | 6,835 |
0 | DISCUSSION | 1 | 8) | [
"B8",
"B9"
] | 17,427,647 | NA|NA|pmid-10356155|pmid-10356155|pmid-9226216|pmid-1944469|pmid-1594625|pmid-10714367|pmid-3773215|pmid-10646121 | Although typical MAS is relatively rare, FD of the bone not associated with either skin pigmentation or endocrine disturbances is a frequent and usually serious skeletal disorder9). | [
"8)",
"9)"
] | 181 | 39,585 | 0 | false | Although typical MAS is relatively rare, FD of the bone not associated with either skin pigmentation or endocrine disturbances is a frequent and usually serious skeletal disorder9). | [] | Although typical MAS is relatively rare, FD of the bone not associated with either skin pigmentation or endocrine disturbances is a frequent and usually serious skeletal disorder9). | true | true | true | true | true | 6,835 |
1 | DISCUSSION | 1 | 10 | [
"B10",
"B12"
] | 17,427,647 | NA|NA | Only three cases of typical or atypical MAS have been reported in Korea10-12). | [
"10",
"12)"
] | 78 | 39,586 | 0 | false | Only three cases of typical or atypical MAS have been reported in Korea10-12). | [] | Only three cases of typical or atypical MAS have been reported in Korea10-12). | true | true | true | true | true | 6,836 |
1 | DISCUSSION | 1 | 10 | [
"B10",
"B12"
] | 17,427,647 | NA|NA | Bony fibrous dysplasia most commonly occurs in the proximal femur and at the base of the skull. | [
"10",
"12)"
] | 95 | 39,587 | 0 | false | Bony fibrous dysplasia most commonly occurs in the proximal femur and at the base of the skull. | [] | Bony fibrous dysplasia most commonly occurs in the proximal femur and at the base of the skull. | true | true | true | true | true | 6,836 |
1 | DISCUSSION | 1 | 10 | [
"B10",
"B12"
] | 17,427,647 | NA|NA | FD of the skeleton usually presents with a limp or pain but occasionally a pathologic fracture may be the presenting sign. | [
"10",
"12)"
] | 122 | 39,588 | 0 | false | FD of the skeleton usually presents with a limp or pain but occasionally a pathologic fracture may be the presenting sign. | [] | FD of the skeleton usually presents with a limp or pain but occasionally a pathologic fracture may be the presenting sign. | true | true | true | true | true | 6,836 |
1 | DISCUSSION | 1 | 10 | [
"B10",
"B12"
] | 17,427,647 | NA|NA | FD of the craniofacial bones can cause visual disturbances, proptosis, nasal obstructions, facial asymmetry or hearing abnormalities. | [
"10",
"12)"
] | 133 | 39,589 | 0 | false | FD of the craniofacial bones can cause visual disturbances, proptosis, nasal obstructions, facial asymmetry or hearing abnormalities. | [] | FD of the craniofacial bones can cause visual disturbances, proptosis, nasal obstructions, facial asymmetry or hearing abnormalities. | true | true | true | true | true | 6,836 |
2 | DISCUSSION | 1 | 3 | [
"B3",
"B4",
"B13",
"B14"
] | 17,427,647 | pmid-10356155|pmid-9226216|pmid-1624678|pmid-1424186 | The endocrine disorders accompanying MAS are precocious puberty, pituitary adenomas secreting growth hormone and/or prolactin, Cushing syndrome, hypophosphatemic osteomalacia, thyroid abnormalities (hyperthyroidism and benign and malignant thyroid nodule) and hyperparathyroidism3, 4, 13). | [
"3",
"4",
"13)",
"14)"
] | 289 | 39,590 | 0 | false | The endocrine disorders accompanying MAS are precocious puberty, pituitary adenomas secreting growth hormone and/or prolactin, Cushing syndrome, hypophosphatemic osteomalacia, thyroid abnormalities (hyperthyroidism and benign and malignant thyroid nodule) and hyperparathyroidism3, 4, 13). | [] | The endocrine disorders accompanying MAS are precocious puberty, pituitary adenomas secreting growth hormone and/or prolactin, Cushing syndrome, hypophosphatemic osteomalacia, thyroid abnormalities (hyperthyroidism and benign and malignant thyroid nodule) and hyperparathyroidism3, 4, 13). | true | true | true | true | true | 6,837 |
2 | DISCUSSION | 1 | 3 | [
"B3",
"B4",
"B13",
"B14"
] | 17,427,647 | pmid-10356155|pmid-9226216|pmid-1624678|pmid-1424186 | Growth hormone hypersecretion in MAS is common but differs from that observed in classic acromegaly in several aspects. | [
"3",
"4",
"13)",
"14)"
] | 119 | 39,591 | 0 | false | Growth hormone hypersecretion in MAS is common but differs from that observed in classic acromegaly in several aspects. | [] | Growth hormone hypersecretion in MAS is common but differs from that observed in classic acromegaly in several aspects. | true | true | true | true | true | 6,837 |
2 | DISCUSSION | 1 | 3 | [
"B3",
"B4",
"B13",
"B14"
] | 17,427,647 | pmid-10356155|pmid-9226216|pmid-1624678|pmid-1424186 | Patients are generally young at onset and are diagnosed based on the observation of growth acceleration rather than from the facial dysmorphism, which is usually difficult to assess due to fibrous dysplasia14). | [
"3",
"4",
"13)",
"14)"
] | 210 | 39,592 | 0 | false | Patients are generally young at onset and are diagnosed based on the observation of growth acceleration rather than from the facial dysmorphism, which is usually difficult to assess due to fibrous dysplasia14). | [] | Patients are generally young at onset and are diagnosed based on the observation of growth acceleration rather than from the facial dysmorphism, which is usually difficult to assess due to fibrous dysplasia14). | true | true | true | true | true | 6,837 |
2 | DISCUSSION | 1 | 3 | [
"B3",
"B4",
"B13",
"B14"
] | 17,427,647 | pmid-10356155|pmid-9226216|pmid-1624678|pmid-1424186 | MAS with a GH excess has a distinct clinical phenotype that is characterized by the TRH responsiveness, prolactin co-secretion, small or absent pituitary tumors, a consistent but inadequate response to a treatment with cabergoline, and an intermediate response to sandostatin LAR. | [
"3",
"4",
"13)",
"14)"
] | 280 | 39,593 | 0 | false | MAS with a GH excess has a distinct clinical phenotype that is characterized by the TRH responsiveness, prolactin co-secretion, small or absent pituitary tumors, a consistent but inadequate response to a treatment with cabergoline, and an intermediate response to sandostatin LAR. | [] | MAS with a GH excess has a distinct clinical phenotype that is characterized by the TRH responsiveness, prolactin co-secretion, small or absent pituitary tumors, a consistent but inadequate response to a treatment with cabergoline, and an intermediate response to sandostatin LAR. | true | true | true | true | true | 6,837 |
2 | DISCUSSION | 1 | 3 | [
"B3",
"B4",
"B13",
"B14"
] | 17,427,647 | pmid-10356155|pmid-9226216|pmid-1624678|pmid-1424186 | Vision and hearing deficits are more common in MAS with an excess of GH than in those without an excess. | [
"3",
"4",
"13)",
"14)"
] | 104 | 39,594 | 0 | false | Vision and hearing deficits are more common in MAS with an excess of GH than in those without an excess. | [] | Vision and hearing deficits are more common in MAS with an excess of GH than in those without an excess. | true | true | true | true | true | 6,837 |
2 | DISCUSSION | 1 | 3 | [
"B3",
"B4",
"B13",
"B14"
] | 17,427,647 | pmid-10356155|pmid-9226216|pmid-1624678|pmid-1424186 | Patients with precocious puberty and an excess of GH have achieved a normal adult height despite a history of early epiphyseal fusion. | [
"3",
"4",
"13)",
"14)"
] | 134 | 39,595 | 0 | false | Patients with precocious puberty and an excess of GH have achieved a normal adult height despite a history of early epiphyseal fusion. | [] | Patients with precocious puberty and an excess of GH have achieved a normal adult height despite a history of early epiphyseal fusion. | true | true | true | true | true | 6,837 |
3 | DISCUSSION | 1 | 9) | [
"B9",
"B5",
"B15",
"B14",
"B16",
"B17",
"B18",
"B19",
"B4"
] | 17,427,647 | pmid-10646121|pmid-1944469|pmid-10036690|pmid-1424186|pmid-7714111|pmid-11397839|NA|pmid-2754454|pmid-9226216 | MAS syndrome is the result of an activating mutation of the alpha subunit of the Gs protein (GNAS1 gene), which causes the constitutive activation of adenylate cyclase. | [
"9)",
"5)",
"15)",
"14",
"16",
"17)",
"18",
"19)",
"4)"
] | 168 | 39,596 | 0 | false | MAS syndrome is the result of an activating mutation of the alpha subunit of the Gs protein (GNAS1 gene), which causes the constitutive activation of adenylate cyclase. | [] | MAS syndrome is the result of an activating mutation of the alpha subunit of the Gs protein (GNAS1 gene), which causes the constitutive activation of adenylate cyclase. | true | true | true | true | true | 6,838 |
3 | DISCUSSION | 1 | 9) | [
"B9",
"B5",
"B15",
"B14",
"B16",
"B17",
"B18",
"B19",
"B4"
] | 17,427,647 | pmid-10646121|pmid-1944469|pmid-10036690|pmid-1424186|pmid-7714111|pmid-11397839|NA|pmid-2754454|pmid-9226216 | In all published cases of MAS, mutations of GS at the R201 position have been identified9). | [
"9)",
"5)",
"15)",
"14",
"16",
"17)",
"18",
"19)",
"4)"
] | 91 | 39,597 | 0 | false | In all published cases of MAS, mutations of GS at the R201 position have been identified9). | [] | In all published cases of MAS, mutations of GS at the R201 position have been identified9). | true | true | true | true | true | 6,838 |
3 | DISCUSSION | 1 | 9) | [
"B9",
"B5",
"B15",
"B14",
"B16",
"B17",
"B18",
"B19",
"B4"
] | 17,427,647 | pmid-10646121|pmid-1944469|pmid-10036690|pmid-1424186|pmid-7714111|pmid-11397839|NA|pmid-2754454|pmid-9226216 | The unproven but accepted explanation for the lack of vertical transmission, along with the observation that the skin and bone lesions tend to lateralize, is that the disease results from postzygotic mutations. | [
"9)",
"5)",
"15)",
"14",
"16",
"17)",
"18",
"19)",
"4)"
] | 210 | 39,598 | 0 | false | The unproven but accepted explanation for the lack of vertical transmission, along with the observation that the skin and bone lesions tend to lateralize, is that the disease results from postzygotic mutations. | [] | The unproven but accepted explanation for the lack of vertical transmission, along with the observation that the skin and bone lesions tend to lateralize, is that the disease results from postzygotic mutations. | true | true | true | true | true | 6,838 |
3 | DISCUSSION | 1 | 9) | [
"B9",
"B5",
"B15",
"B14",
"B16",
"B17",
"B18",
"B19",
"B4"
] | 17,427,647 | pmid-10646121|pmid-1944469|pmid-10036690|pmid-1424186|pmid-7714111|pmid-11397839|NA|pmid-2754454|pmid-9226216 | Hence, the patients are referred to as somatic mosaics. | [
"9)",
"5)",
"15)",
"14",
"16",
"17)",
"18",
"19)",
"4)"
] | 55 | 39,599 | 0 | false | Hence, the patients are referred to as somatic mosaics. | [] | Hence, the patients are referred to as somatic mosaics. | true | true | true | true | true | 6,838 |
3 | DISCUSSION | 1 | 9) | [
"B9",
"B5",
"B15",
"B14",
"B16",
"B17",
"B18",
"B19",
"B4"
] | 17,427,647 | pmid-10646121|pmid-1944469|pmid-10036690|pmid-1424186|pmid-7714111|pmid-11397839|NA|pmid-2754454|pmid-9226216 | The mosaicism could explain the varied clinical picture of those with this syndrome5). | [
"9)",
"5)",
"15)",
"14",
"16",
"17)",
"18",
"19)",
"4)"
] | 86 | 39,600 | 0 | false | The mosaicism could explain the varied clinical picture of those with this syndrome5). | [] | The mosaicism could explain the varied clinical picture of those with this syndrome5). | true | true | true | true | true | 6,838 |
3 | DISCUSSION | 1 | 9) | [
"B9",
"B5",
"B15",
"B14",
"B16",
"B17",
"B18",
"B19",
"B4"
] | 17,427,647 | pmid-10646121|pmid-1944469|pmid-10036690|pmid-1424186|pmid-7714111|pmid-11397839|NA|pmid-2754454|pmid-9226216 | The percentage of cells with the GNAS1 mutation out of a total number of cells in each tissue might be very low due to the mosaicism. | [
"9)",
"5)",
"15)",
"14",
"16",
"17)",
"18",
"19)",
"4)"
] | 133 | 39,601 | 0 | false | The percentage of cells with the GNAS1 mutation out of a total number of cells in each tissue might be very low due to the mosaicism. | [] | The percentage of cells with the GNAS1 mutation out of a total number of cells in each tissue might be very low due to the mosaicism. | true | true | true | true | true | 6,838 |
3 | DISCUSSION | 1 | 9) | [
"B9",
"B5",
"B15",
"B14",
"B16",
"B17",
"B18",
"B19",
"B4"
] | 17,427,647 | pmid-10646121|pmid-1944469|pmid-10036690|pmid-1424186|pmid-7714111|pmid-11397839|NA|pmid-2754454|pmid-9226216 | This explains why GS mutations at the R201 position are detected only in the thyroid tissue by direct base sequencing, as in our case. | [
"9)",
"5)",
"15)",
"14",
"16",
"17)",
"18",
"19)",
"4)"
] | 134 | 39,602 | 0 | false | This explains why GS mutations at the R201 position are detected only in the thyroid tissue by direct base sequencing, as in our case. | [] | This explains why GS mutations at the R201 position are detected only in the thyroid tissue by direct base sequencing, as in our case. | true | true | true | true | true | 6,838 |
3 | DISCUSSION | 1 | 9) | [
"B9",
"B5",
"B15",
"B14",
"B16",
"B17",
"B18",
"B19",
"B4"
] | 17,427,647 | pmid-10646121|pmid-1944469|pmid-10036690|pmid-1424186|pmid-7714111|pmid-11397839|NA|pmid-2754454|pmid-9226216 | However, the detection of a mutation in all samples was obtained after using the mutation allele specific amplification method. | [
"9)",
"5)",
"15)",
"14",
"16",
"17)",
"18",
"19)",
"4)"
] | 127 | 39,603 | 0 | false | However, the detection of a mutation in all samples was obtained after using the mutation allele specific amplification method. | [] | However, the detection of a mutation in all samples was obtained after using the mutation allele specific amplification method. | true | true | true | true | true | 6,838 |
3 | DISCUSSION | 1 | 9) | [
"B9",
"B5",
"B15",
"B14",
"B16",
"B17",
"B18",
"B19",
"B4"
] | 17,427,647 | pmid-10646121|pmid-1944469|pmid-10036690|pmid-1424186|pmid-7714111|pmid-11397839|NA|pmid-2754454|pmid-9226216 | FD presents a treatment dilemma because there is no proven medical therapy. | [
"9)",
"5)",
"15)",
"14",
"16",
"17)",
"18",
"19)",
"4)"
] | 75 | 39,604 | 0 | false | FD presents a treatment dilemma because there is no proven medical therapy. | [] | FD presents a treatment dilemma because there is no proven medical therapy. | true | true | true | true | true | 6,838 |
3 | DISCUSSION | 1 | 9) | [
"B9",
"B5",
"B15",
"B14",
"B16",
"B17",
"B18",
"B19",
"B4"
] | 17,427,647 | pmid-10646121|pmid-1944469|pmid-10036690|pmid-1424186|pmid-7714111|pmid-11397839|NA|pmid-2754454|pmid-9226216 | Bisphosphates have been shown to reduce the incidence of fractures and reduce the intensity of bone pain. | [
"9)",
"5)",
"15)",
"14",
"16",
"17)",
"18",
"19)",
"4)"
] | 105 | 39,605 | 0 | false | Bisphosphates have been shown to reduce the incidence of fractures and reduce the intensity of bone pain. | [] | Bisphosphates have been shown to reduce the incidence of fractures and reduce the intensity of bone pain. | true | true | true | true | true | 6,838 |
3 | DISCUSSION | 1 | 9) | [
"B9",
"B5",
"B15",
"B14",
"B16",
"B17",
"B18",
"B19",
"B4"
] | 17,427,647 | pmid-10646121|pmid-1944469|pmid-10036690|pmid-1424186|pmid-7714111|pmid-11397839|NA|pmid-2754454|pmid-9226216 | However, the only cure for FD is a surgical resection, which is difficult in the skull and facial regions. | [
"9)",
"5)",
"15)",
"14",
"16",
"17)",
"18",
"19)",
"4)"
] | 106 | 39,606 | 0 | false | However, the only cure for FD is a surgical resection, which is difficult in the skull and facial regions. | [] | However, the only cure for FD is a surgical resection, which is difficult in the skull and facial regions. | true | true | true | true | true | 6,838 |
3 | DISCUSSION | 1 | 9) | [
"B9",
"B5",
"B15",
"B14",
"B16",
"B17",
"B18",
"B19",
"B4"
] | 17,427,647 | pmid-10646121|pmid-1944469|pmid-10036690|pmid-1424186|pmid-7714111|pmid-11397839|NA|pmid-2754454|pmid-9226216 | Surgery is recommended when there is a functional cranial nerve deficit in order to prevent or limit the permanent loss of function15). | [
"9)",
"5)",
"15)",
"14",
"16",
"17)",
"18",
"19)",
"4)"
] | 135 | 39,607 | 0 | false | Surgery is recommended when there is a functional cranial nerve deficit in order to prevent or limit the permanent loss of function15). | [] | Surgery is recommended when there is a functional cranial nerve deficit in order to prevent or limit the permanent loss of function15). | true | true | true | true | true | 6,838 |
3 | DISCUSSION | 1 | 9) | [
"B9",
"B5",
"B15",
"B14",
"B16",
"B17",
"B18",
"B19",
"B4"
] | 17,427,647 | pmid-10646121|pmid-1944469|pmid-10036690|pmid-1424186|pmid-7714111|pmid-11397839|NA|pmid-2754454|pmid-9226216 | Medical treatment using a somatostatin or dopamine agonist is often the only option in patients with MAS and an excess of GH because transsphenoidal surgery is not possible due to the massive thickening of the skull base with FD14, 16, 17). | [
"9)",
"5)",
"15)",
"14",
"16",
"17)",
"18",
"19)",
"4)"
] | 240 | 39,608 | 0 | false | Medical treatment using a somatostatin or dopamine agonist is often the only option in patients with MAS and an excess of GH because transsphenoidal surgery is not possible due to the massive thickening of the skull base with FD14, 16, 17). | [] | Medical treatment using a somatostatin or dopamine agonist is often the only option in patients with MAS and an excess of GH because transsphenoidal surgery is not possible due to the massive thickening of the skull base with FD14, 16, 17). | true | true | true | true | true | 6,838 |
3 | DISCUSSION | 1 | 9) | [
"B9",
"B5",
"B15",
"B14",
"B16",
"B17",
"B18",
"B19",
"B4"
] | 17,427,647 | pmid-10646121|pmid-1944469|pmid-10036690|pmid-1424186|pmid-7714111|pmid-11397839|NA|pmid-2754454|pmid-9226216 | Radiation therapy is not considered to be an option because it is believed to predispose FD to a sarcomatous transformation18, 19). | [
"9)",
"5)",
"15)",
"14",
"16",
"17)",
"18",
"19)",
"4)"
] | 131 | 39,609 | 0 | false | Radiation therapy is not considered to be an option because it is believed to predispose FD to a sarcomatous transformation18, 19). | [] | Radiation therapy is not considered to be an option because it is believed to predispose FD to a sarcomatous transformation18, 19). | true | true | true | true | true | 6,838 |
3 | DISCUSSION | 1 | 9) | [
"B9",
"B5",
"B15",
"B14",
"B16",
"B17",
"B18",
"B19",
"B4"
] | 17,427,647 | pmid-10646121|pmid-1944469|pmid-10036690|pmid-1424186|pmid-7714111|pmid-11397839|NA|pmid-2754454|pmid-9226216 | Hyperthyroidism in a MAS setting is treated with the same medication options used for treating hyperthyroidism4). | [
"9)",
"5)",
"15)",
"14",
"16",
"17)",
"18",
"19)",
"4)"
] | 113 | 39,610 | 0 | false | Hyperthyroidism in a MAS setting is treated with the same medication options used for treating hyperthyroidism4). | [] | Hyperthyroidism in a MAS setting is treated with the same medication options used for treating hyperthyroidism4). | true | true | true | true | true | 6,838 |
4 | DISCUSSION | 0 | null | null | 17,427,647 | null | Wepresent a case of Typical MAS with FD, skin pigmentation, acromegaly, hyperprolactinemia, and a thyroid nodule in a 23-year-old man. | null | 134 | 39,611 | 0 | false | null | null | Wepresent a case of Typical MAS with FD, skin pigmentation, acromegaly, hyperprolactinemia, and a thyroid nodule in a 23-year-old man. | true | true | true | true | true | 6,839 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3"
] | 21,076,576 | pmid-18487478|pmid-15793191|pmid-19410252 | Recent works suggest a certain cutoff of elevated 1-hour plasma glucose during oral glucose tolerance test (OGTT) is a strong predictor of future risk for type 2 diabetes, suggesting the role of 1-hour post-challenge glucose in the alteration of glucose metabolism status as well as 2-hour post-challenge glucose [1,2]. | [
"1",
"2",
"3"
] | 319 | 39,612 | 0 | false | Recent works suggest a certain cutoff of elevated 1-hour plasma glucose during oral glucose tolerance test (OGTT) is a strong predictor of future risk for type 2 diabetes, suggesting the role of 1-hour post-challenge glucose in the alteration of glucose metabolism status as well as 2-hour post-challenge glucose. | [
"1,2"
] | Recent works suggest a certain cutoff of elevated 1-hour plasma glucose during oral glucose tolerance test (OGTT) is a strong predictor of future risk for type 2 diabetes, suggesting the role of 1-hour post-challenge glucose in the alteration of glucose metabolism status as well as 2-hour post-challenge glucose. | true | true | true | true | true | 6,840 |
0 | INTRODUCTION | 1 | 3 | [
"B1",
"B2",
"B3"
] | 21,076,576 | pmid-18487478|pmid-15793191|pmid-19410252 | A very recent work reported that elevated 1-hour post-load plasma glucose level identifies subjects with normal glucose tolerance but subclinical atherosclerosis measured by carotid intima-media thickness [3]. | [
"1",
"2",
"3"
] | 209 | 39,613 | 1 | false | A very recent work reported that elevated 1-hour post-load plasma glucose level identifies subjects with normal glucose tolerance but subclinical atherosclerosis measured by carotid intima-media thickness. | [
"3"
] | A very recent work reported that elevated 1-hour post-load plasma glucose level identifies subjects with normal glucose tolerance but subclinical atherosclerosis measured by carotid intima-media thickness. | true | true | true | true | true | 6,840 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3"
] | 21,076,576 | pmid-18487478|pmid-15793191|pmid-19410252 | These results imply the importance of acute post-challenge glucose excursions in the development of atherosclerosis. | [
"1",
"2",
"3"
] | 116 | 39,614 | 0 | false | These results imply the importance of acute post-challenge glucose excursions in the development of atherosclerosis. | [] | These results imply the importance of acute post-challenge glucose excursions in the development of atherosclerosis. | true | true | true | true | true | 6,840 |
1 | INTRODUCTION | 1 | 4 | [
"B4",
"B5",
"B6",
"B7",
"B8",
"B9"
] | 21,076,576 | pmid-17581229|pmid-17611734|pmid-14567500|pmid-16401315|pmid-17785928|pmid-18607561|pmid-12615661|pmid-18607561|pmid-12615661|pmid-14662706|pmid-14698999|pmid-12379578|pmid-14698999|pmid-12560165|pmid-12695300|pmid-12379578 | Arterial stiffness is an independent predictor of cardiovascular morbidity and mortality [4,5]. | [
"4",
"5",
"6",
"7",
"8",
"9"
] | 95 | 39,615 | 0 | false | Arterial stiffness is an independent predictor of cardiovascular morbidity and mortality. | [
"4,5"
] | Arterial stiffness is an independent predictor of cardiovascular morbidity and mortality. | true | true | true | true | true | 6,841 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.